# The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy

> **NCT07039474** · — · NOT_YET_RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Solid Tumors and Hematological Tumors

## Interventions

- **DRUG:** 18F-G1

## Key facts

- **NCT ID:** NCT07039474
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07039474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07039474, "The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer Immunotherapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07039474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*